RAP
Click for more information
0.00% 20.5¢ resapp health limited

Ann: Medgate commences European ResAppDx trial, page-3

  1. Bloky
    1,912 Posts.
    lightbulb Created with Sketch. 1585
    clock Created with Sketch.
    04/03/21
    09:19
    Post #: 51504215
    Dr Andy Fischer, CEO Medgate said: "We are absolutely convinced that the use of new technologies like ResAppDx will enable an advancement of our Digital Health platform. This will benefit our patients by enabling them to be treated conclusively by phone or video in even more cases
    RAP Price at posting: 5.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 44  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

NEWS Are there gains to be made with the grocery giants?
right-arrow Created with Sketch.
AUQ Alara forced to push back copper concentrate production
right-arrow Created with Sketch.
NEWS Australia continues to beef up domestic crit mineral supply chains
right-arrow Created with Sketch.
RCE Recce weighs in on Q1 2024 as cash increases 100%
right-arrow Created with Sketch.
NEWS Join our Daily Newsletter to gain exclusive insights into HotCopper!
right-arrow Created with Sketch.
NEWS Brent Crude and gold surge as Israel attacks Iran
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.